Value creation in Life Sciences 66: Musings with Luis Pareras MD, PhD Managing...
A less technical but very engaging conversation that answers many questions a biotech entrepreneur might have. Some of the topics we discussed: …and many more…
Value creation in Life Sciences 65: Musings with Luis Pareras MD, PhD Managing...
“A reader lives a thousand lives before he dies… The man who never reads lives only one.” I had the opportunity to read his book and wanted to discuss a few insights that could help the audience apply these learnings…
Value creation in Life Sciences 64: When Should Life Sciences Companies Contact...
A less technical but very engaging conversation that answers many questions a biotech eThe classic dilemma: Contacting strategic investors too early often results in the response: “Come back when you have the data!” So, what is the right approach? How…
Productivity Paradox: Evaluating People in the Intangible Industry
Jordi Anderson, after spending 25 years in the manufacturing industry, invests in biotech and becomes the Chief Business Officer (CBO). He has been measuring productivity based on metrics such as output per labor hour and production volume, and methods like…
Timeless Truths – What Won’t Change in the Future
When Jeff Bezos was asked to predict what’s going to change in 10 years, he said that what’s not going to change in 10 years is a better question because we could build our business based on that. He mentioned…
Value creation in Life Sciences 63: What Pre-Money Valuation is Good for Me?
A lesA million-dollar question every biotech/medtech entrepreneur faces. As I get ready to attend #BIOEQUITY in San Sebastián this Sunday on behalf of Attgeno, I wanted to share a quick insight on pre-money valuation and how we should think about…
Decision Making: Are You on the Pareto Frontier?
Have you experimented with this intriguing approach to meaningful comparison? When I was graduating from my bachelor’s degree, the single attribute everyone cared about after landing a job was salary. Comparing ourselves to others is not country-specific—it’s a global phenomenon….
Value creation in Life Sciences 62: Musings with Kåre Engkilde, PhD,...
Kåre has worn numerous hats throughout his career. From the pharmaceutical industry to CEO at Magle Biopharma, he now leads BII, spearheading the innovative SpaceM project—a pioneering single-cell metabolomics platform. In this discussion, we explore: 1. CEO Aptitude 2. IPO…
How Indians (Hindi Region) Are Losing Their Mother Tongue
I learnt the importance of mother tongue when I moved to Europe 16 years ago. I observed that a Spanish would NEVER talk to another Spanish in English, an Italian would never do the same and so on. This pattern…
Value Creation in Life Sciences 61: Musings with Gabriele Campi, PhD, CEO of...
I had an engaging conversation with Gabriele Campi, where we explored several thought-provoking topics: …and much more. Thanks for watching!
